| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 1.60e-04 | 25 | 85 | 3 | GO:0000979 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.78e-04 | 5 | 85 | 2 | GO:0061628 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | PLXNA3 TPR CAMKK2 RESF1 CARMIL2 RAB3GAP2 KDR DYNC1H1 MFF SPAG5 HTT | 2.61e-05 | 574 | 86 | 11 | GO:0010638 |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 5.14e-05 | 3 | 86 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | anatomical structure arrangement | 8.82e-05 | 21 | 86 | 3 | GO:0048532 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | PLXNA3 TPR CAMKK2 EFNB1 RESF1 CARMIL2 PTPRD ARID2 RAB3GAP2 KDR ANKRD23 DYNC1H1 TUBG1 MFF SPAG5 HTT | 1.20e-04 | 1342 | 86 | 16 | GO:0033043 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | BOC PLXNA3 KIF13B EFNB1 PTPRD RAPH1 USP9X LRP2 KDR DMD PARD3 ADAM10 | 1.20e-04 | 802 | 86 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | BOC PLXNA3 KIF13B EFNB1 PTPRD RAPH1 USP9X LRP2 KDR DMD PARD3 ADAM10 | 1.46e-04 | 819 | 86 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | PLXNA3 TPR CAMKK2 RESF1 CARMIL2 PTPRD FRMPD4 RAB3GAP2 LRP2 KDR DMD PARD3 DYNC1H1 MFF SPAG5 HTT | 1.47e-04 | 1366 | 86 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | cell division | TPR CENPT DIS3L2 HMCN1 USP9X AKNA PARD3 DYNC1H1 SPAG5 CDK4 SON | 1.48e-04 | 697 | 86 | 11 | GO:0051301 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | BOC PLXNA3 KIF13B EFNB1 PTPRD RAPH1 USP9X LRP2 KDR DMD PARD3 ADAM10 | 1.58e-04 | 826 | 86 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 1.70e-04 | 280 | 86 | 7 | GO:1902115 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.37e-04 | 596 | 84 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | pronucleus | 1.91e-04 | 28 | 84 | 3 | GO:0045120 | |
| Domain | TAF_II_230-bd | 2.14e-05 | 2 | 87 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 2.14e-05 | 2 | 87 | 2 | IPR022591 | |
| Domain | - | 2.14e-05 | 2 | 87 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 2.14e-05 | 2 | 87 | 2 | PF09247 | |
| Domain | DUF3591 | 2.14e-05 | 2 | 87 | 2 | PF12157 | |
| Domain | TAF1_animal | 2.14e-05 | 2 | 87 | 2 | IPR011177 | |
| Domain | Znf_C2H2_matrin | 1.37e-03 | 12 | 87 | 2 | IPR000690 | |
| Domain | ARM-like | 1.64e-03 | 270 | 87 | 6 | IPR011989 | |
| Domain | TIL_dom | 1.88e-03 | 14 | 87 | 2 | IPR002919 | |
| Domain | Ig_I-set | 1.95e-03 | 190 | 87 | 5 | IPR013098 | |
| Domain | ig | 1.95e-03 | 190 | 87 | 5 | PF00047 | |
| Domain | Immunoglobulin | 1.95e-03 | 190 | 87 | 5 | IPR013151 | |
| Domain | I-set | 1.95e-03 | 190 | 87 | 5 | PF07679 | |
| Domain | ZF_MATRIN | 3.13e-03 | 18 | 87 | 2 | PS50171 | |
| Domain | TNFR_c6 | 4.66e-03 | 22 | 87 | 2 | PF00020 | |
| Domain | IGc2 | 4.84e-03 | 235 | 87 | 5 | SM00408 | |
| Domain | Ig_sub2 | 4.84e-03 | 235 | 87 | 5 | IPR003598 | |
| Pubmed | TPR GTF3C2 RAPH1 AMOT USP9X ARID2 RAB3GAP2 CIZ1 ZNF318 TAF1 PARD3 DYNC1H1 ZMYM4 HTT | 1.12e-10 | 549 | 88 | 14 | 38280479 | |
| Pubmed | TPR RESF1 GTF3C2 RAPH1 AMOT RAB3GAP2 LRP2 ZNF318 TAF1 ZMYM4 SPAG5 | 9.26e-09 | 418 | 88 | 11 | 34709266 | |
| Pubmed | 1.88e-07 | 335 | 88 | 9 | 15741177 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B RIF1 PDE8A GTF3C2 AMOT GPS1 CIZ1 BCKDHA E2F5 PARD3 HDAC7 CLUH DYNC1H1 TUBG1 SPAG5 CDK4 | 1.89e-07 | 1321 | 88 | 16 | 27173435 |
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 8.69e-07 | 8 | 88 | 3 | 1974879 | |
| Pubmed | 9.53e-07 | 407 | 88 | 9 | 12693553 | ||
| Pubmed | 1.06e-06 | 71 | 88 | 5 | 33541421 | ||
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 2055107 | ||
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 2.55e-06 | 11 | 88 | 3 | 2034278 | |
| Pubmed | TPR KIF13B FAM184B TNFRSF9 RESF1 FLYWCH1 AMOT OBSCN LRP2 OTUD4 ZNF318 PARD3 SPAG5 | 3.36e-06 | 1084 | 88 | 13 | 11544199 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.17e-06 | 774 | 88 | 11 | 15302935 | |
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 4.40e-06 | 13 | 88 | 3 | 1740345 | |
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 8012115 | ||
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 4.40e-06 | 13 | 88 | 3 | 1772416 | |
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 7805729 | ||
| Pubmed | 4.86e-06 | 497 | 88 | 9 | 23414517 | ||
| Pubmed | 6.05e-06 | 101 | 88 | 5 | 10997877 | ||
| Pubmed | KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo. | 6.33e-06 | 2 | 88 | 2 | 34670814 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 20668203 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26193666 | ||
| Pubmed | KIF13B mediates VEGFR2 recycling to modulate vascular permeability. | 6.33e-06 | 2 | 88 | 2 | 36928770 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25424701 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 38804708 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22842574 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27571988 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 34403156 | ||
| Pubmed | A zinc finger protein that represses transcription of the human MHC class II gene, DPA. | 6.33e-06 | 2 | 88 | 2 | 8568247 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23145961 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27462448 | ||
| Pubmed | KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2. | 6.33e-06 | 2 | 88 | 2 | 25128562 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10070062 | ||
| Pubmed | Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. | 6.33e-06 | 2 | 88 | 2 | 12881722 | |
| Pubmed | Huntingtin regulates mammary stem cell division and differentiation. | 1.24e-05 | 18 | 88 | 3 | 24749073 | |
| Pubmed | 1.36e-05 | 57 | 88 | 4 | 38223760 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 31361762 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 33800462 | ||
| Pubmed | Transcriptional activation of REST by Sp1 in Huntington's disease models. | 1.90e-05 | 3 | 88 | 2 | 21179468 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 16822332 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 1.90e-05 | 3 | 88 | 2 | 11592977 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 1.90e-05 | 3 | 88 | 2 | 16407123 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.22e-05 | 332 | 88 | 7 | 32786267 | |
| Pubmed | RIF1 GTF3C2 FLYWCH1 ARID2 CIZ1 OTUD4 ZNF318 CMSS1 PARD3 TAF1L ZMYM4 MFF AQR SON | 2.29e-05 | 1497 | 88 | 14 | 31527615 | |
| Pubmed | 2.33e-05 | 22 | 88 | 3 | 33899739 | ||
| Pubmed | 2.56e-05 | 136 | 88 | 5 | 25429064 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR PER2 GTF3C2 ARID2 GPS1 CIZ1 TYMP DYNC1H1 ZMYM4 TUBG1 AQR SPAG5 | 3.42e-05 | 1155 | 88 | 12 | 20360068 |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 25942483 | ||
| Pubmed | Huntingtin facilitates dynein/dynactin-mediated vesicle transport. | 3.79e-05 | 4 | 88 | 2 | 17548833 | |
| Pubmed | Nuclear Mitotic Apparatus (NuMA) Interacts with and Regulates Astrin at the Mitotic Spindle. | 3.79e-05 | 4 | 88 | 2 | 27462074 | |
| Pubmed | Polyglutamine expansion of huntingtin impairs its nuclear export. | 3.79e-05 | 4 | 88 | 2 | 15654337 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 18818406 | ||
| Pubmed | The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. | 3.79e-05 | 4 | 88 | 2 | 28096290 | |
| Pubmed | 5.91e-05 | 162 | 88 | 5 | 25826454 | ||
| Pubmed | RIF1 RESF1 GTF3C2 USP9X ARID2 LRP2 OTUD4 ZNF318 TAF1 SUFU TAF1L DYNC1H1 ZMYM4 | 6.15e-05 | 1429 | 88 | 13 | 35140242 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 20705734 | ||
| Pubmed | mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease. | 6.30e-05 | 5 | 88 | 2 | 32859226 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 25387128 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23880157 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23926101 | ||
| Pubmed | The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. | 6.30e-05 | 5 | 88 | 2 | 9920925 | |
| Pubmed | A two-kinesin mechanism controls neurogenesis in the developing brain. | 6.30e-05 | 5 | 88 | 2 | 38040957 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 22965144 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B RESF1 CARMIL2 RAPH1 AMOT RAB3GAP2 PARD3 HDAC7 AQR DOP1A | 6.49e-05 | 861 | 88 | 10 | 36931259 |
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 6.68e-05 | 31 | 88 | 3 | 25838543 | |
| Pubmed | 8.07e-05 | 173 | 88 | 5 | 36217029 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | FAM120B USP9X RAB3GAP2 GPS1 OTUD4 BCKDHA PARD3 HDAC7 DYNC1H1 NACA4P CDK4 SON | 9.40e-05 | 1284 | 88 | 12 | 17353931 |
| Pubmed | Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. | 9.43e-05 | 6 | 88 | 2 | 19525941 | |
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 18922795 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 19959467 | ||
| Pubmed | RESF1 ARID2 CIZ1 LRP2 BCKDHA ZNF318 TAF1 TNFRSF10B PARD3 TUBG1 SON | 1.18e-04 | 1116 | 88 | 11 | 31753913 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | 1.23e-04 | 931 | 88 | 10 | 27432908 | |
| Pubmed | TPR ZFAT DIS3L2 USP9X ARID2 RAB3GAP2 REST CRAMP1 ZMYM4 HTT GABPB1 CDK4 | 1.28e-04 | 1327 | 88 | 12 | 32694731 | |
| Pubmed | Nudel functions in membrane traffic mainly through association with Lis1 and cytoplasmic dynein. | 1.32e-04 | 7 | 88 | 2 | 14970193 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 9990854 | ||
| Pubmed | Spatial regulation of VEGF receptor endocytosis in angiogenesis. | 1.32e-04 | 7 | 88 | 2 | 23354168 | |
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 1.34e-04 | 39 | 88 | 3 | 25944111 | |
| Pubmed | 1.45e-04 | 104 | 88 | 4 | 10470851 | ||
| Pubmed | 1.50e-04 | 604 | 88 | 8 | 38803224 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.50e-04 | 954 | 88 | 10 | 36373674 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.57e-04 | 608 | 88 | 8 | 36089195 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.71e-04 | 203 | 88 | 5 | 22083510 | |
| Pubmed | 1.72e-04 | 322 | 88 | 6 | 26514267 | ||
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 1.75e-04 | 8 | 88 | 2 | 28826662 | |
| Pubmed | 1.75e-04 | 8 | 88 | 2 | 30914652 | ||
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 1.75e-04 | 8 | 88 | 2 | 1675191 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 1.75e-04 | 8 | 88 | 2 | 2034279 | |
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 1.75e-04 | 8 | 88 | 2 | 8468051 | |
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 1.75e-04 | 8 | 88 | 2 | 31012985 | |
| Pubmed | 2.09e-04 | 634 | 88 | 8 | 34591612 | ||
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 12665565 | ||
| Pubmed | GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas. | 2.25e-04 | 9 | 88 | 2 | 23446420 | |
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 9751712 | ||
| Pubmed | Molecular characterization of ENU mouse mutagenesis and archives. | 2.25e-04 | 9 | 88 | 2 | 16139793 | |
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 2.25e-04 | 9 | 88 | 2 | 7874112 | |
| Pubmed | 2.54e-04 | 653 | 88 | 8 | 22586326 | ||
| Pubmed | 2.65e-04 | 49 | 88 | 3 | 17567985 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.65e-04 | 1024 | 88 | 10 | 24711643 | |
| Pubmed | Genome-wide association study of co-occurring anxiety in major depression. | 2.81e-04 | 10 | 88 | 2 | 24047446 | |
| Pubmed | 2.94e-04 | 503 | 88 | 7 | 16964243 | ||
| Pubmed | 3.04e-04 | 506 | 88 | 7 | 30890647 | ||
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.65e-04 | 161 | 58 | 5 | 593 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.85e-04 | 51 | 58 | 3 | 870 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-08 | 184 | 88 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-08 | 184 | 88 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-08 | 184 | 88 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.77e-06 | 184 | 88 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 162 | 88 | 5 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 170 | 88 | 5 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.68e-05 | 177 | 88 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 177 | 88 | 5 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 182 | 88 | 5 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 185 | 88 | 5 | 4e40d3103ebf4a7066b7ce300b6ef700ba0e2863 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 186 | 88 | 5 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.40e-05 | 186 | 88 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.48e-05 | 187 | 88 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.05e-05 | 193 | 88 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.05e-05 | 193 | 88 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.15e-05 | 194 | 88 | 5 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.68e-05 | 199 | 88 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| Disease | Colorectal Carcinoma | 6.20e-06 | 702 | 86 | 11 | C0009402 | |
| Disease | Malignant neoplasm of breast | BOC RIF1 PTPRD PER2 RAPH1 CYP3A4 OBSCN KDR ZNF318 DMD ADAM10 HDAC7 DOP1A | 1.36e-05 | 1074 | 86 | 13 | C0006142 |
| Disease | vital capacity | FAM184B ZFAT MTMR11 DIS3L2 PTPRD HMCN1 LRP2 OTUD4 KDR LTBP2 CMSS1 PARD3 GABPB1 | 5.82e-05 | 1236 | 86 | 13 | EFO_0004312 |
| Disease | tauro-beta-muricholate measurement | 8.35e-05 | 5 | 86 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 8.35e-05 | 5 | 86 | 2 | EFO_0800569 | |
| Disease | Mental Retardation, X-Linked 1 | 1.12e-04 | 32 | 86 | 3 | C2931498 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.25e-04 | 6 | 86 | 2 | EFO_0800294 | |
| Disease | prostatic hypertrophy (biomarker_via_orthology) | 1.75e-04 | 7 | 86 | 2 | DOID:11132 (biomarker_via_orthology) | |
| Disease | Parkinson disease, disease progression measurement | 2.02e-04 | 39 | 86 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | high grade glioma (is_marker_for) | 2.53e-04 | 42 | 86 | 3 | DOID:3070 (is_marker_for) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 2.98e-04 | 9 | 86 | 2 | EFO_0800278 | |
| Disease | Gastrointestinal Stromal Sarcoma | 3.53e-04 | 47 | 86 | 3 | C3179349 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 3.72e-04 | 10 | 86 | 2 | EFO_0800289 | |
| Disease | Gastrointestinal Stromal Tumors | 4.24e-04 | 50 | 86 | 3 | C0238198 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 4.54e-04 | 11 | 86 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 4.54e-04 | 11 | 86 | 2 | EFO_0800295 | |
| Disease | Squamous cell carcinoma of the head and neck | 4.76e-04 | 52 | 86 | 3 | C1168401 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 5.44e-04 | 12 | 86 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 5.44e-04 | 12 | 86 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 6.41e-04 | 13 | 86 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 7.47e-04 | 14 | 86 | 2 | EFO_0800817 | |
| Disease | Malformations of Cortical Development | 7.47e-04 | 14 | 86 | 2 | C1955869 | |
| Disease | nephroblastoma (is_implicated_in) | 7.47e-04 | 14 | 86 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Cortical Dysplasia | 7.47e-04 | 14 | 86 | 2 | C0431380 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 7.47e-04 | 14 | 86 | 2 | EFO_0800283 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 8.60e-04 | 15 | 86 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 9.81e-04 | 16 | 86 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 9.81e-04 | 16 | 86 | 2 | EFO_0800305 | |
| Disease | dehydroepiandrosterone sulphate measurement | 1.04e-03 | 68 | 86 | 3 | EFO_0007001 | |
| Disease | susceptibility to mononucleosis measurement | 1.09e-03 | 69 | 86 | 3 | EFO_0008403 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.25e-03 | 18 | 86 | 2 | EFO_0800288 | |
| Disease | metabolonic lactone sulfate measurement | 1.39e-03 | 19 | 86 | 2 | EFO_0800659 | |
| Disease | etiocholanolone glucuronide measurement | 1.39e-03 | 19 | 86 | 2 | EFO_0800362 | |
| Disease | urinary bladder cancer (is_implicated_in) | 1.44e-03 | 76 | 86 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | anthropometric measurement | 1.50e-03 | 168 | 86 | 4 | EFO_0004302 | |
| Disease | X-24947 measurement | 1.87e-03 | 22 | 86 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 1.87e-03 | 22 | 86 | 2 | EFO_0021115 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.98e-03 | 447 | 86 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 1.98e-03 | 447 | 86 | 6 | C3714756 | |
| Disease | Prostatic Neoplasms | 2.16e-03 | 616 | 86 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.16e-03 | 616 | 86 | 7 | C0376358 | |
| Disease | glioblastoma (is_implicated_in) | 2.22e-03 | 24 | 86 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | mean reticulocyte volume | 2.31e-03 | 799 | 86 | 8 | EFO_0010701 | |
| Disease | epiandrosterone sulfate measurement | 2.41e-03 | 25 | 86 | 2 | EFO_0021120 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TPIQILGQEPDAEMV | 1066 | Q4VCS5 | |
| QTPVMLPQDSGQRVE | 61 | Q5SNV9 | |
| EPVSPDTMENIQGNI | 306 | Q8NHU2 | |
| PQSQAQVEPVGLEMF | 101 | Q86SG2 | |
| QMTGVEEVTQIPQEE | 186 | O14672 | |
| EVQAMALQETPPQVT | 71 | Q6F5E8 | |
| TPTVEEQMDTVTGPN | 536 | Q86TY3 | |
| SPMEPQGTLDITQQD | 1391 | Q68CP9 | |
| DTEVMQQETVPVPVP | 31 | Q9BQ75 | |
| AQEPIQMPETTETVL | 211 | P20036 | |
| MVTGENINSVEPAQP | 826 | Q5JWR5 | |
| LPPAMVEEGEEVQNQ | 1386 | O60306 | |
| PVQTVLEGDNMETPV | 3396 | P11532 | |
| EPEDMEQEPAQQVIT | 821 | Q8IYB7 | |
| ESGALPVPQESIMEN | 726 | Q9UPM8 | |
| PVPQESIMENVDQAI | 731 | Q9UPM8 | |
| AMLVVPQAETQGPVE | 16 | Q9HC84 | |
| AEISEQPTMATVVPQ | 1136 | Q70E73 | |
| QTEASVNGQMPQPEI | 771 | Q01804 | |
| EVVDVNDNPPEVMVS | 336 | Q9Y5F3 | |
| AMDPQDLQNTEVPIA | 1341 | Q9H2M9 | |
| PAPDEPVQMEVVQEG | 646 | Q13127 | |
| PVQMEVVQEGPAQKE | 651 | Q13127 | |
| ELPPPMETAQTEVAQ | 686 | Q13127 | |
| VESAPMQVVQKEPVQ | 716 | Q13127 | |
| PSQQREMENGIVPTK | 266 | Q7Z3D4 | |
| MVGNTVELPEEENTP | 131 | P62166 | |
| FQEGVPNASVIMQVP | 66 | Q9GZY8 | |
| NIAPQKEEPEMGSVQ | 11 | A4FU01 | |
| EEQGGVVQPALEMPE | 86 | Q4VC44 | |
| EPGQGPEMQEVLLEV | 186 | Q9ULE4 | |
| MPDGQQVLTVPATDI | 301 | Q06547 | |
| DPQLAPNVVVTEAVM | 926 | Q86SJ6 | |
| DGQQPVLAITDPDMI | 76 | P08684 | |
| PQPSQVPLQEDVDMS | 21 | O15055 | |
| QEPDSMAGVIVEQGQ | 146 | P51805 | |
| QTDEEKQQGLPVVMP | 751 | O60658 | |
| QGAVEPMQIDVDPQE | 11 | Q13098 | |
| LSTQEDVMVPVSGNP | 726 | P98164 | |
| YVPPNIMGEEQNVSV | 2101 | Q96RW7 | |
| PPSMQVTIEDVQAQT | 6356 | Q5VST9 | |
| QVVDVNDNPPQVTMS | 336 | Q9NRJ7 | |
| VTQPLVMEQEESPPE | 2476 | P42858 | |
| NVQVFEPPEVTMELS | 316 | Q9BWV1 | |
| TQLEVPIPEMGQNGQ | 196 | Q15329 | |
| PVQSVVPEMEESGAQ | 256 | P11802 | |
| PGDQIVMINDEPVSA | 116 | Q14CM0 | |
| IVLEDTQPFSQPMVG | 236 | Q96BT3 | |
| QEEQSMTPPGKVVTV | 761 | Q96RY5 | |
| IMKVGQDPNAVTPEQ | 161 | P98172 | |
| GQEVVVVDTPSFNQM | 486 | Q8ND71 | |
| MNEPVSGQEPTKVSQ | 201 | P28358 | |
| LPQQGRQLDMTEEEP | 111 | Q7Z591 | |
| VNIQDTMIGELPPQT | 276 | Q8NFQ5 | |
| PMPEQGIAEIQEEQV | 816 | Q14767 | |
| VFELVNQGPVMEVPT | 266 | Q96RR4 | |
| QGEVPEPQDMKVAEV | 496 | Q14204 | |
| DTPMPELQVGPQEQE | 51 | Q8WUI4 | |
| GVENITQLPQELPQM | 6 | Q8TC92 | |
| DPTNVGPEVKQQVTM | 556 | Q96EK7 | |
| MQIEEAGQTTPVEPN | 516 | Q5THK1 | |
| VMDRQGQIINPSEDP | 81 | P12694 | |
| QLSPTVNMPQDDTVI | 746 | Q8TEW0 | |
| DGMITVQLPEVPANE | 1121 | P23468 | |
| EEAQPEMGPDVLVQT | 1506 | Q9NQT8 | |
| PGVEGVNPMTQINQV | 1176 | Q93008 | |
| NLVEMESQEAPGPAV | 311 | Q96R06 | |
| ENTPPVVISADQMVN | 1386 | Q5UIP0 | |
| QITPVMPENAERQTP | 456 | Q9HCM1 | |
| VIREEPQQNMSQPEV | 566 | Q8IZX4 | |
| GVIKEEPQQNMSQPE | 546 | P21675 | |
| VTFEEPVVQMEQPSL | 816 | Q9Y6H5 | |
| PVVQMEQPSLELNGE | 821 | Q9Y6H5 | |
| PEPVGTQVSMEEIQN | 506 | Q9ULV3 | |
| GIEPFSLQVSPQEMV | 56 | O75153 | |
| ANNETGIVMPVPEIS | 196 | Q96I15 | |
| EAMQPVEEQAVEQPA | 1226 | Q9P243 | |
| IPMQQILEEAEPQGQ | 206 | Q53GI3 | |
| VFPNQDEMSDVVVQP | 171 | P23258 | |
| QEAMQSEGPVEHVPV | 1726 | P12270 | |
| EDPQMQPVQTPFGVV | 181 | Q9UMX1 | |
| QPFMRPVQTTQEEDG | 226 | Q07011 | |
| VSILQPTQVPEQEME | 276 | O14763 | |
| PTQVPEQEMEVQEPA | 281 | O14763 | |
| EQEMEVQEPAEPTGV | 286 | O14763 | |
| PVGNMTVVDSPGQEV | 16 | Q8WUA4 | |
| PEITLQPDMQPTEQE | 551 | P35968 | |
| MEEPTAVEGQVQLPS | 1 | Q96HH4 | |
| VINEETTPPVMEQPV | 1201 | Q6ZQQ6 | |
| QVPMNSEVIVDPIQG | 11 | Q68DY9 | |
| EDNMVPQGMPEQETT | 2251 | Q5VUA4 | |
| PQGMPEQETTVGAIQ | 2256 | Q5VUA4 | |
| IPGFNVIQSPEQMQV | 161 | P19971 | |
| QPVTTTELEQPVGMT | 506 | P18583 | |
| EVPVGVEMAENTDNP | 1451 | Q5VZL5 | |
| MPGEATETVPAIEQQ | 1 | Q9BZK3 |